Nanomedicine: Nanotechnology; Biology and Medicine. 2024; 56(February 2024); 102730
Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.
Nature Communications. 2024; 15(1); 2528
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Journal of Controlled Release. 2023; 353(January); 549-562
Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models
eLife. 2023; 12(Jan 27); e79342
Regulatory T cells suppress the formation of potent KLRK1 and IL- 7R expressing effector CD8 T cells by limiting IL-2
Cell Death & Disease. 2023; 14(3); 209
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Trends in Immunology. 2023; 44(11); 890-901
IL-2-driven CD8+ T cell phenotypes: implications for immunotherapy
Pharmaceutics. 2022; 14(6); 1201